My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 93

1.

Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy.

Ponte-Sucre A.

Kinetoplastid Biol Dis. 2003 Oct 28;2(1):14.PMID: 14613496 [PubMed - as supplied by publisher]Free PMC ArticleFree textRelated citations

2.

Antiparasitic chemotherapy: tinkering with the purine salvage pathway.

Datta AK, Datta R, Sen B.

Adv Exp Med Biol. 2008;625:116-32. Review.PMID: 18365663 [PubMed - indexed for MEDLINE]Related citations

3.

[Development of antituberculous drugs: current status and future prospects]

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese. PMID: 17240921 [PubMed - indexed for MEDLINE]Related citations

4.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related citations

5.

Molecular biological assessment methods and understanding the course of the HIV infection.

Katzenstein TL.

APMIS Suppl. 2003;(114):1-37. Review.PMID: 14626050 [PubMed - indexed for MEDLINE]Related citations

6.

[Frontier of mycobacterium research--host vs. mycobacterium]

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese. PMID: 16245793 [PubMed - indexed for MEDLINE]Related citations

7.

[Leishmania: role of P glycoprotein in drug resistance and reversion strategies]

Osorio EJ, Robledo SM, Arango GJ, Muskus CE.

Biomedica. 2005 Jun;25(2):242-60. Review. Spanish. PMID: 16022379 [PubMed - indexed for MEDLINE]Related citations

8.

[Interpretation of laboratory data during cryptic leishmaniasis in dog]

Gravino AE.

Parassitologia. 2004 Jun;46(1-2):227-9. Italian. PMID: 15305723 [PubMed - indexed for MEDLINE]Related citations

9.

The resumption of consumption -- a review on tuberculosis.

Ducati RG, Ruffino-Netto A, Basso LA, Santos DS.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714. Review.PMID: 17160276 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

10.

API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.

API Consensus Expert Committee.

J Assoc Physicians India. 2006 Mar;54:219-34.PMID: 16800350 [PubMed - indexed for MEDLINE]Related citations

11.

Genetically modified live attenuated parasites as vaccines for leishmaniasis.

Selvapandiyan A, Duncan R, Debrabant A, Lee N, Sreenivas G, Salotra P, Nakhasi HL.

Indian J Med Res. 2006 Mar;123(3):455-66. Review.PMID: 16778323 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

12.

HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis.

Santos LO, Marinho FA, Altoé EF, Vitório BS, Alves CR, Britto C, Motta MC, Branquinha MH, Santos AL, d'Avila-Levy CM.

PLoS One. 2009;4(3):e4918. Epub 2009 Mar 26.PMID: 19325703 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

13.

[Tuberculosis in compromised hosts]

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese. PMID: 14672050 [PubMed - indexed for MEDLINE]Related citations

14.

Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies.

Suzuki E, Tanaka AK, Toledo MS, Levery SB, Straus AH, Takahashi HK.

Biochim Biophys Acta. 2008 Mar;1780(3):362-9. Epub 2007 Sep 25. Review.PMID: 17976917 [PubMed - indexed for MEDLINE]Related citations

15.

Chemosensitizers in drug transport mechanisms involved in protozoan resistance.

Pradines B, Pagès JM, Barbe J.

Curr Drug Targets Infect Disord. 2005 Dec;5(4):411-31. Review.PMID: 16535862 [PubMed - indexed for MEDLINE]Related citations

16.

Role of intracellular cAMP in differentiation-coupled induction of resistance against oxidative damage in Leishmania donovani.

Bhattacharya A, Biswas A, Das PK.

Free Radic Biol Med. 2008 Mar 1;44(5):779-94. Epub 2007 Nov 21.PMID: 18078824 [PubMed - indexed for MEDLINE]Related citations

17.

Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host.

Naderer T, Vince JE, McConville MJ.

Curr Mol Med. 2004 Sep;4(6):649-65. Review.PMID: 15357214 [PubMed - indexed for MEDLINE]Related citations

18.

Leishmania spp.: proficiency of drug-resistant parasites.

Natera S, Machuca C, Padrón-Nieves M, Romero A, Díaz E, Ponte-Sucre A.

Int J Antimicrob Agents. 2007 Jun;29(6):637-42. Epub 2007 Mar 13. Review.PMID: 17353113 [PubMed - indexed for MEDLINE]Related citations

19.

Prokaryotic expression, purification, and polyclonal antibody production against a novel drug resistance gene of Leishmania donovani clinical isolate.

Kothari H, Kumar P, Singh N.

Protein Expr Purif. 2006 Jan;45(1):15-21. Epub 2005 Oct 26.PMID: 16289919 [PubMed - indexed for MEDLINE]Related citations

20.

Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania.

Cortés-Selva F, Jiménez IA, Munoz-Martínez F, Campillo M, Bazzocchi IL, Pardo L, Ravelo AG, Castanys S, Gamarro F.

Curr Pharm Des. 2005;11(24):3125-39. Review.PMID: 16178749 [PubMed - indexed for MEDLINE]Related citations

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk